Recital 17, Regulation (EU) 2026/1388

In forcesince 17 Jun 2026

In order to ensure legal certainty, this Regulation should set out the criteria to ascertain if an NGT plant is equivalent to naturally occurring or conventionally bred plants (‘criteria of equivalence’) and lay down a procedure for competent authorities to verify, and take a decision on, the fulfilment of those criteria before NGT plants or NGT products are deliberately released or placed on the market, as category 1 NGT plants or products. The criteria of equivalence should be fulfilled in the plant that is to be deliberately released or placed on the market as a category 1 NGT plant. Any genetic modifications temporarily introduced during the development of the NGT plant and removed from the plant that is to be deliberately released or placed on the market should not be relevant for the verification of the criteria of equivalence. Those criteria should be objective and based on up-to-date scientific knowledge. They should cover the types and extent of genetic modifications that can be observed in nature or in plants obtained by conventional breeding techniques and should include upper limits for the size of genetic modifications, the number of genetic modifications per protein-coding sequence and the overall number of genetic modifications per NGT plant. As regards the number of genetic modifications, the criteria of equivalence should reflect the complexity of plant genomes. Therefore, the upper limit for the total number of individual modifications per plant for the plant to qualify as a category 1 NGT plant should be proportionate to the number of genome copies (‘ploidy’) of the plant.